Mohawk, West Pharma, and Ambev Exceed Expectations with Strong Q4 Earnings

Three major publicly traded companies—Mohawk Industries, West Pharmaceutical Services, and Ambev SA—reported fourth-quarter financial results that significantly exceeded analyst estimates. Mohawk Industries reported an earnings per share (EPS) of $2.00 on revenue of $2.7 billion, surpassing market expectations by $0.02. West Pharmaceutical Services also beat expectations with an EPS of $2.04 and issued optimistic guidance for fiscal year 2026, targeting between $7.85 and $8.20 per share. Ambev SA delivered a substantial surprise, announcing an EPS of $0.280, which far outpaced the analyst consensus of $0.051. The strong performance across these diverse sectors was driven by robust operational execution during the final quarter of the year. Positive earnings surprises and upward revisions to future guidance are expected to bolster investor confidence and drive immediate stock price appreciation.